Cardiovascular Primary Prevention Full Text
JAMA Internal Medicine,  Clinical Article

Prasad V et al. - Large studies must show improvements in overall mortality before novel agents are recommended and used. The implications of this proposal are considered.

  • Recent trials in cardiovascular medicine have contradicted current practice, and, accordingly, are medical reversals.
  • Extended-release niacin and fenofibrate have failed to provide mortality benefit when added to statin therapy, though both drugs have been used for this purpose for years.
  • Cardiovascular primary prevention is no small matter.
  • Annual spending on statins exceeded $19 billion in 2005, ezetimibe cost over $5 billion in 2007, and fenofibrate costs passed $1 billion in 2009.
  • Given the tremendous price of these medications, and recent trials that have undermined years of practice, the authors propose that the bar for cardiovascular primary prevention has been raised.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Physician Assistant

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Physician Assistant Articles

1 Rice consumption and risk of cardiovascular disease: Results from a pooled analysis of 3 U.S. cohorts American Journal of Clinical Nutrition, December 2, 2014    Clinical Article

2 Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial The Lancet Oncology, October 22, 2014    Clinical Article

3 Nonobstructive coronary artery disease and risk of myocardial infarction JAMA, November 6, 2014    Evidence Based Medicine    Clinical Article

4 Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives Diabetes Care, January 5, 2015    Clinical Article

5 Effects of regular consumption of different forms of almonds and hazelnuts on acceptance and blood lipids European Journal of Nutrition, December 12, 2014    Clinical Article

6 Comparative study of glucose homeostasis, lipids and lipoproteins, HDL functionality, and cardiometabolic parameters in modestly severely obese African Americans and White Americans with prediabetes: implications for the metabolic paradoxes Diabetes Care, December 24, 2014    Clinical Article

7 Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies Annals of Oncology, January 23, 2015    Clinical Article

8 Nivolumab for metastatic renal cell carcinoma: Results of a randomized phase II trial Journal of Clinical Oncology, January 2, 2015    Clinical Article

9 Nutritional and physical activity interventions to improve immunity American Journal of Lifestyle Medicine, December 12, 2014    Review Article

10 Dietary fat increases vitamin D-3 absorption Journal of the Academy of Nutrition and Dietetics, December 5, 2014    Clinical Article

11 Breath analysis in inflammatory bowel diseases Alimentary Pharmacology and Therapeutics, December 24, 2014    Review Article

12 Effects of physical activity and exercise training on cardiovascular risk in coronary artery disease patients with and without type 2 diabetes Diabetes Care, January 23, 2015    Clinical Article

13 Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial The Lancet, January 26, 2015    Evidence Based Medicine    Clinical Article

14 A metabolomics approach to the identification of biomarkers of sugar-sweetened beverage intake American Journal of Clinical Nutrition, January 23, 2015    Clinical Article

15 The costs of inadequate breastfeeding of infants in Mexico American Journal of Clinical Nutrition, January 9, 2015    Clinical Article

16 PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2–targeted therapies in breast cancer Journal of Clinical Oncology, January 22, 2015    Clinical Article

17 Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the clinical index of stable febrile neutropenia in a prospective cohort of patients from the FINITE study Journal of Clinical Oncology, January 16, 2015    Clinical Article

18 Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): Final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study The Lancet Oncology, January 23, 2015    Clinical Article

19 Male pattern baldness in relation to prostate cancer risks: An analysis in the Vitamins and lifestyle (VITAL) cohort study The Prostate, December 12, 2014    Clinical Article

20 Vitamin supplementation on the risk of venous thrombosis: results from the MEGA case-control study American Journal of Clinical Nutrition, January 23, 2015    Clinical Article

Indexed Journals in Physician Assistant: Advance for Physicians Assistants, American Family Physicianmore

Looking for a physician job? Let us help!

Register now for our free job placement service.
A career consultant will contact you soon.
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List